A phase III clinical trial of anti-pseudomonas aeruginosa IgY in the treatment of cystic fibrosis.
Phase of Trial: Phase III
Latest Information Update: 25 Oct 2011
At a glance
- Drugs Anti pseudomonas aeruginosa IgY (Primary)
- Indications Bacterial infections; Cystic fibrosis
- Focus Therapeutic Use
- 25 Oct 2011 New trial record